In addition, we collected serum from 272 clinical patients at four stages, including healthy controls (HC), ulcerative colitis (UC), pre‐cancer (PC), and colorectal cancer (CRC) patients, and detected the expression of KLK1 in serum. Here, KLK1 is linked to colorectal carcinoma.